Torti Frank is a director of Arbutus Biopharma Corp.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Immunovant, Inc.
4 Apr 24
4
Arbutus Biopharma Corp
26 May 23
4
Immunovant, Inc.
14 Apr 23
4
Immunovant, Inc.
29 Sep 22
4
Immunovant, Inc.
19 Aug 22
4
Arbutus Biopharma Corp
26 May 22
4
Immunovant, Inc.
12 Jan 22
4
Arbutus Biopharma Corp
7 Jun 21
4
Sio Gene Therapies Inc.
19 Apr 21
4
Immunovant, Inc.
23 Mar 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Apr 24 | IMVT Immunovant | Common Stock | Grant | Acquire A | No | No | 0 | 120,400 | 0.00 | 635,674 |
2 Apr 24 | IMVT Immunovant | Stock Option Common Stock | Grant | Acquire A | No | No | 30.78 | 50,167 | 1.54 mm | 50,167 |
24 May 23 | ABUS Arbutus Biopharma | Stock Option Common Shares | Grant | Acquire A | No | No | 2.56 | 55,000 | 140.80 k | 55,000 |
12 Apr 23 | IMVT Immunovant | Common Stock | Grant | Acquire A | No | No | 0 | 121,916 | 0.00 | 515,274 |
12 Apr 23 | IMVT Immunovant | Stock Option Common Stock | Grant | Acquire A | No | No | 14.7 | 158,292 | 2.33 mm | 158,292 |